key: cord-1037488-sqc0bbhh
authors: Speeckaert, Marijn M.; Speeckaert, Reinhart; Delanghe, Joris R.
title: The biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
date: 2021-05-23
journal: Eur J Pediatr
DOI: 10.1007/s00431-021-04110-2
sha: 4bb9a7cb5d0a67a58874c96c0a23085b0191d9c2
doc_id: 1037488
cord_uid: sqc0bbhh

nan

With interest, we read the paper of Bayramoğlu et al. [1] , which showed an association between vitamin D deficiency and clinical severity in children and adolescents with COVID-19. Besides the investigated parameters, we would like to highlight the potential influence of vitamin D binding protein (DBP) polymorphism on the reported findings.

Being one of the most abundant serum proteins, DBP transports 85-90% of vitamin D metabolites, whereas 10-15% is more loosely bound to albumin and <0.1% circulates in an unbound form. DBP is characterized by three major alleles, determined by two SNPs (rs7041 and rs4588): DBP1F (rs7041-T/rs4588-C), DBP1S (rs7041-G/rs4588-C), and DBP2 (rs7041-T/rs4588-A), yielding six allelic combinations and corresponding phenotypes: 3 homozygous (DBP1F/1F, DBP 1S/1S, DBP 2/2) and 3 heterozygous (DBP 1F/2, DBP 1F/1S, DBP1S/2) [2] . The DBP gene is one of the genes involved in the variation of 25-hydroxy vitamin D (25OHD) concentrations. In several studies with adults and children, minor alleles of rs7041 and rs4588, but also of other DBP SNPs (rs2282679 and rs1155563), have been linked with lower 25OHD concentrations [3] . 25OHD and DBP concentrations are highest in DBP1-1, intermediate in DBP1-2, and lowest in DBP2-2 individuals [2] . In infants, the DBP1S/1S, DBP1S/1F, and DBP1F/1F group showed higher serum 25OHD concentrations from birth onward and a significantly better response to 24-month high-dose supplementation of 30 μg/day vitamin D 3 in comparison with the DBP1S/2, DBP 1F/ 2, and DBP 2/2 group [3] . Moreover, the DBP1 allele frequency has been associated with a lower prevalence and mortality due to a SARS-CoV-2 infection, which could be partly explained by potential protective effects of vitamin D and DBP (actin scavenging, hemotaxis, influence on T cell response, …) [4] .

In conclusion, the DBP polymorphism could influence the reported vitamin D concentrations in children with COVID-19 and should be taken into account in future studies. 

Conflict of interest The authors declare no competing interests.

The association between vitamin D levels and the clinical severity and inflammation markers in pediatric Communicated by Peter de Winter COVID-19 patients: single-center experience from a pandemic hospital

Vitamin D binding protein: a multifunctional protein of clinical importance

Genetic variation of the vitamin D binding protein affects vitamin D status and response to supplementation in infants

Vitamin D binding protein polymorphism and COVID-19

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations